Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Herrlinger

Showing results (71-80 of 243) with videos related to

Pageof 25
Sort By:
Cancers|October 27, 2020
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype GlioblastomaSied Kebir, Teresa Schmidt, Matthias Weber, et al.
Cancer Medicine|November 29, 2016
Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastomaAndreas Müller, Alina Jurcoane, Sied Kebir, et al.
Journal of Neuro-Oncology|September 29, 2020
Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality ratesMatthias Schneider, Inja Ilic, Anna-Laura Potthoff, et al.
Neuro-Oncology|September 4, 2016
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastasesSied Kebir, Laurèl Rauschenbach, Norbert Galldiks, et al.
Journal of Cancer Research and Clinical Oncology|June 20, 2016
The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastomaChristina Schaub, Niklas Schäfer, Frederic Mack, et al.
Neurology|December 14, 2019
Olfactory function as an independent prognostic factor in glioblastomaSied Kebir, Elke Hattingen, Michael Niessen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomideMartin Glas, Caroline Happold, Johannes Rieger, et al.
Journal of Neurosurgery|October 11, 2024
Visual deterioration secondary to medial sphenoid wing meningioma: systematic assessment of patient-reported outcomes and factors contributing to recovery after surgical treatmentFlorian Gessler, Shefqet Hajdari, Anna-Laura Potthoff, et al.
Journal of the Advanced Practitioner in Oncology|June 14, 2023
Distress in Neuro-Oncology Patients and Its Implications for CommunicationCarolin Roos, Johannes Weller, Christiane Landwehr, et al.
Oncology|January 20, 2021
Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III GliomasIris Divé, Eike Steidl, Marlies Wagner, et al.
Pageof 25

Showing results (71-80 of 243) with videos related to

Sort By:
Pageof 25
Cancers|October 27, 2020
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype GlioblastomaSied Kebir, Teresa Schmidt, Matthias Weber, et al.
Cancer Medicine|November 29, 2016
Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastomaAndreas Müller, Alina Jurcoane, Sied Kebir, et al.
Journal of Neuro-Oncology|September 29, 2020
Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality ratesMatthias Schneider, Inja Ilic, Anna-Laura Potthoff, et al.
Neuro-Oncology|September 4, 2016
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastasesSied Kebir, Laurèl Rauschenbach, Norbert Galldiks, et al.
Journal of Cancer Research and Clinical Oncology|June 20, 2016
The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastomaChristina Schaub, Niklas Schäfer, Frederic Mack, et al.
Neurology|December 14, 2019
Olfactory function as an independent prognostic factor in glioblastomaSied Kebir, Elke Hattingen, Michael Niessen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomideMartin Glas, Caroline Happold, Johannes Rieger, et al.
Journal of Neurosurgery|October 11, 2024
Visual deterioration secondary to medial sphenoid wing meningioma: systematic assessment of patient-reported outcomes and factors contributing to recovery after surgical treatmentFlorian Gessler, Shefqet Hajdari, Anna-Laura Potthoff, et al.
Journal of the Advanced Practitioner in Oncology|June 14, 2023
Distress in Neuro-Oncology Patients and Its Implications for CommunicationCarolin Roos, Johannes Weller, Christiane Landwehr, et al.
Oncology|January 20, 2021
Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III GliomasIris Divé, Eike Steidl, Marlies Wagner, et al.
Pageof 25